METHSCOPOLAMINE BROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methscopolamine Bromide patents expire, and when can generic versions of Methscopolamine Bromide launch?
Methscopolamine Bromide is a drug marketed by Bayshore Pharms Llc, Breckenridge Pharm, Chartwell Rx, Ne Rx Pharma, and Pvt Form. and is included in five NDAs.
The generic ingredient in METHSCOPOLAMINE BROMIDE is methscopolamine bromide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methscopolamine Bromide
A generic version of METHSCOPOLAMINE BROMIDE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHSCOPOLAMINE BROMIDE?
- What are the global sales for METHSCOPOLAMINE BROMIDE?
- What is Average Wholesale Price for METHSCOPOLAMINE BROMIDE?
Summary for METHSCOPOLAMINE BROMIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 876 |
| What excipients (inactive ingredients) are in METHSCOPOLAMINE BROMIDE? | METHSCOPOLAMINE BROMIDE excipients list |
| DailyMed Link: | METHSCOPOLAMINE BROMIDE at DailyMed |
Pharmacology for METHSCOPOLAMINE BROMIDE
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for METHSCOPOLAMINE BROMIDE
US Patents and Regulatory Information for METHSCOPOLAMINE BROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayshore Pharms Llc | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 200602-001 | Sep 24, 2012 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-001 | Feb 1, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Breckenridge Pharm | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 040642-002 | Dec 6, 2011 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ne Rx Pharma | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 216786-002 | Feb 1, 2024 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bayshore Pharms Llc | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 200602-002 | Sep 24, 2012 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Breckenridge Pharm | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 040642-001 | Dec 6, 2011 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | METHSCOPOLAMINE BROMIDE | methscopolamine bromide | TABLET;ORAL | 040624-002 | Dec 28, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
